256 related articles for article (PubMed ID: 31326971)
1. PVT1 Promotes Angiogenesis by Regulating miR-29c/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway in Non-Small-Cell Lung Cancer (NSCLC).
Mao Z; Xu B; He L; Zhang G
Med Sci Monit; 2019 Jul; 25():5418-5425. PubMed ID: 31326971
[TBL] [Abstract][Full Text] [Related]
2. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
Qi G; Li L
Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195.
Wu D; Li Y; Zhang H; Hu X
Cell Physiol Biochem; 2017; 42(6):2453-2466. PubMed ID: 28848163
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
Han J; Hu J; Sun F; Bian H; Tang B; Fang X
Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
7. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.
Wei CM; Zhao XF; Qiu HB; Ming Z; Liu K; Yan J
Neoplasma; 2020 Jul; 67(4):802-812. PubMed ID: 32202906
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling.
Xue D; Yang Y; Liu Y; Wang P; Dai Y; Liu Q; Chen L; Shen J; Ju H; Li Y; Tan Z
Oncotarget; 2016 Nov; 7(48):79805-79813. PubMed ID: 27806334
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
11. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
Chen L; Han X; Hu Z; Chen L
Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368
[TBL] [Abstract][Full Text] [Related]
12. PVT1 induces NSCLC cell migration and invasion by regulating IL-6 via sponging miR-760.
Su XH; Zhu YR; Hou YJ; Li K; Dong NH
Mol Cell Probes; 2020 Dec; 54():101652. PubMed ID: 32866660
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
[TBL] [Abstract][Full Text] [Related]
15. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma.
Liu L; Bi N; Wu L; Ding X; Men Y; Zhou W; Li L; Zhang W; Shi S; Song Y; Wang L
Mol Cancer; 2017 Feb; 16(1):50. PubMed ID: 28241836
[TBL] [Abstract][Full Text] [Related]
17. LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer.
Hou Y; Jia H; Cao Y; Zhang S; Zhang X; Wei P; Xie J; Dong W; Wang B
Life Sci; 2021 Feb; 267():118933. PubMed ID: 33359744
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA.
Zhan S; Wang C; Yin F
Mol Med Rep; 2018 May; 17(5):6705-6710. PubMed ID: 29512752
[TBL] [Abstract][Full Text] [Related]
20. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.
Lingling J; Xiangao J; Guiqing H; Jichan S; Feifei S; Haiyan Z
Biomed Pharmacother; 2019 Apr; 112():108648. PubMed ID: 30780105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]